Barclays’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.7M Buy
279,812
+147,473
+111% +$7.2M ﹤0.01% 980
2025
Q1
$6.74M Sell
132,339
-31,509
-19% -$1.61M ﹤0.01% 1247
2024
Q4
$7.4M Sell
163,848
-3,164
-2% -$143K ﹤0.01% 1317
2024
Q3
$6.2M Buy
167,012
+102,138
+157% +$3.79M ﹤0.01% 1368
2024
Q2
$1.98M Sell
64,874
-28,024
-30% -$857K ﹤0.01% 1715
2024
Q1
$2.7M Sell
92,898
-160,404
-63% -$4.67M ﹤0.01% 1736
2023
Q4
$6.98M Buy
253,302
+110,652
+78% +$3.05M ﹤0.01% 1272
2023
Q3
$3.2M Buy
142,650
+30,435
+27% +$682K ﹤0.01% 1392
2023
Q2
$4.56M Buy
112,215
+27,124
+32% +$1.1M ﹤0.01% 1279
2023
Q1
$4.12M Sell
85,091
-46,855
-36% -$2.27M ﹤0.01% 1194
2022
Q4
$5.04M Sell
131,946
-120
-0.1% -$4.58K ﹤0.01% 1115
2022
Q3
$6.63M Buy
132,066
+108,178
+453% +$5.43M 0.01% 969
2022
Q2
$957K Sell
23,888
-30,556
-56% -$1.22M ﹤0.01% 2115
2022
Q1
$2.03M Sell
54,444
-41,298
-43% -$1.54M ﹤0.01% 1766
2021
Q4
$3.81M Buy
95,742
+36,302
+61% +$1.45M ﹤0.01% 1407
2021
Q3
$2.21M Buy
59,440
+43,802
+280% +$1.63M ﹤0.01% 1792
2021
Q2
$661K Sell
15,638
-70,943
-82% -$3M ﹤0.01% 2327
2021
Q1
$4.1M Sell
86,581
-23,497
-21% -$1.11M ﹤0.01% 1339
2020
Q4
$6.72M Sell
110,078
-4,593
-4% -$280K ﹤0.01% 900
2020
Q3
$5.36M Sell
114,671
-42,200
-27% -$1.97M ﹤0.01% 939
2020
Q2
$7.96M Sell
156,871
-18,276
-10% -$927K 0.01% 744
2020
Q1
$7.81M Buy
175,147
+8,341
+5% +$372K 0.01% 698
2019
Q4
$8.01M Sell
166,806
-121,499
-42% -$5.83M ﹤0.01% 952
2019
Q3
$9.75M Buy
288,305
+131,140
+83% +$4.43M 0.01% 782
2019
Q2
$7.07M Buy
157,165
+98,301
+167% +$4.42M ﹤0.01% 943
2019
Q1
$2.22M Buy
58,864
+20,362
+53% +$767K ﹤0.01% 1484
2018
Q4
$1.32M Sell
38,502
-11,930
-24% -$410K ﹤0.01% 1634
2018
Q3
$2.37M Buy
50,432
+6,570
+15% +$309K ﹤0.01% 1649
2018
Q2
$1.48M Sell
43,862
-200,337
-82% -$6.77M ﹤0.01% 1599
2018
Q1
$6.61M Buy
244,199
+213,145
+686% +$5.77M 0.01% 829
2017
Q4
$518K Sell
31,054
-26
-0.1% -$434 ﹤0.01% 2064
2017
Q3
$622K Sell
31,080
-59,881
-66% -$1.2M ﹤0.01% 1800
2017
Q2
$1.67M Buy
90,961
+13,753
+18% +$252K ﹤0.01% 1303
2017
Q1
$759K Buy
77,208
+52,869
+217% +$520K ﹤0.01% 1719
2016
Q4
$265K Sell
24,339
-64,817
-73% -$706K ﹤0.01% 2164
2016
Q3
$1.25M Buy
89,156
+74,352
+502% +$1.04M ﹤0.01% 1304
2016
Q2
$103K Buy
14,804
+238
+2% +$1.66K ﹤0.01% 2329
2016
Q1
$87K Sell
14,566
-417,716
-97% -$2.49M ﹤0.01% 2366
2015
Q4
$13.8M Buy
432,282
+83,130
+24% +$2.66M 0.02% 383
2015
Q3
$9.08M Buy
349,152
+296,127
+558% +$7.7M 0.01% 505
2015
Q2
$2.55M Buy
53,025
+50,264
+1,820% +$2.41M ﹤0.01% 1073
2015
Q1
$166K Sell
2,761
-152
-5% -$9.14K ﹤0.01% 2335
2014
Q4
$148K Buy
2,913
+451
+18% +$22.9K ﹤0.01% 2498
2014
Q3
$108K Sell
2,462
-3,960
-62% -$174K ﹤0.01% 2602
2014
Q2
$167K Buy
6,422
+2,077
+48% +$54K ﹤0.01% 2472
2014
Q1
$112K Buy
4,345
+4,110
+1,749% +$106K ﹤0.01% 2716
2013
Q4
$3K Sell
235
-307
-57% -$3.92K ﹤0.01% 4118
2013
Q3
$11K Buy
+542
New +$11K ﹤0.01% 3639